Kadant Inc. KAI
301.00 USD +18.21 (+6.44%)
Nov 4, 2026, 10:57 AM EST
297.88 Day range 320.18
244.87 52-week range 354.07
- YTD
- +5.61%
- 1 year
- +10.04%
Analyst view
Price target (mean) 357.50 +18.8% upside
Now 301.00
- Target (low)
- 335.00
- Target (mean)
- 357.50
- Target (high)
- 380.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
- Strong buy1
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.86 | 2.43 – 3.05 | 2.59 | +10.3% | 302.14M | +11.3% | 4 |
| Next quarter | 3.27 | 2.91 – 3.58 | 2.27 | +44.0% | 302.39M | +5.7% | 4 |
| Current year | 12.04 | 10.54 – 12.59 | 9.26 | +30.0% | 1.20B | +13.9% | 4 |
| Next year | 13.51 | 11.82 – 14.40 | 12.04 | +12.3% | 1.27B | +5.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| May 4, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 19, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 18, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 9, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| Feb 4, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| Feb 3, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 30, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 29, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 27, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 10, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 23, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 4, 2025 | DA Davidson | Maintained | Neutral | Neutral |
| Jul 30, 2025 | Barrington Research | Reiterated | Outperform | Outperform |
| Jul 29, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| May 1, 2025 | DA Davidson | Maintained | Neutral | Neutral |
| May 1, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Apr 30, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Apr 25, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 18, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 14, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Dec 19, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 30, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 20, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 1, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| Jun 26, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Jun 5, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| May 1, 2024 | Barrington Research | Maintained | Outperform | Outperform |
